Natarajan Vaishaali, Harris Edward N, Kidambi Srivatsan
Department of Chemical and Biomolecular Engineering, University of Nebraska, Lincoln, NE, USA.
Department of Biochemistry, University of Nebraska, Lincoln, NE, USA; Nebraska Center for Integrated Biomolecular Communication, University of Nebraska, Lincoln, NE, USA; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA; Nebraska Center for the Prevention of Obesity Diseases, University of Nebraska, Lincoln, NE, USA.
Biomed Res Int. 2017;2017:4097205. doi: 10.1155/2017/4097205. Epub 2017 Feb 15.
Liver fibrosis is a wound-healing response to chronic liver injury such as alcoholic/nonalcoholic fatty liver disease and viral hepatitis with no FDA-approved treatments. Liver fibrosis results in a continual accumulation of extracellular matrix (ECM) proteins and paves the way for replacement of parenchyma with nonfunctional scar tissue. The fibrotic condition results in drastic changes in the local mechanical, chemical, and biological microenvironment of the tissue. Liver parenchyma is supported by an efficient network of vasculature lined by liver sinusoidal endothelial cells (LSECs). These nonparenchymal cells are highly specialized resident endothelial cell type with characteristic morphological and functional features. Alterations in LSECs phenotype including lack of LSEC fenestration, capillarization, and formation of an organized basement membrane have been shown to precede fibrosis and promote hepatic stellate cell activation. Here, we review the interplay of LSECs with the dynamic changes in the fibrotic liver microenvironment such as matrix rigidity, altered ECM protein profile, and cell-cell interactions to provide insight into the pivotal changes in LSEC physiology and the extent to which it mediates the progression of liver fibrosis. Establishing the molecular aspects of LSECs in the light of fibrotic microenvironment is valuable towards development of novel therapeutic and diagnostic targets of liver fibrosis.
肝纤维化是对慢性肝损伤(如酒精性/非酒精性脂肪性肝病和病毒性肝炎)的一种伤口愈合反应,目前尚无美国食品药品监督管理局(FDA)批准的治疗方法。肝纤维化会导致细胞外基质(ECM)蛋白持续积累,为用无功能的瘢痕组织替代实质组织铺平道路。纤维化状态会导致组织局部的机械、化学和生物微环境发生剧烈变化。肝实质由肝窦内皮细胞(LSEC)内衬的高效血管网络支撑。这些非实质细胞是具有特征性形态和功能特征的高度特化的驻留内皮细胞类型。已表明LSEC表型的改变,包括LSEC窗孔缺失、毛细血管化以及有组织的基底膜形成,在纤维化之前就已出现,并促进肝星状细胞活化。在此,我们综述LSEC与纤维化肝微环境动态变化(如基质硬度、ECM蛋白谱改变和细胞间相互作用)之间的相互作用,以深入了解LSEC生理学的关键变化及其介导肝纤维化进展的程度。根据纤维化微环境确定LSEC的分子层面,对于开发肝纤维化的新型治疗和诊断靶点具有重要价值。